Status | Study |
Completed |
Study Name: Intestinal Function in Neonates With Complex Congenital Heart Disease Condition: Congenital Heart Defects Growth Failure Date: 2011-10-06 Interventions: Other: Arm 1: NPO by mouth pre-operative |
Completed |
Study Name: Cyproheptadine as an Appetite Stimulant Condition: Failure to Thrive Date: 2011-03-14 Interventions: Drug: Cyproheptadine 0,25mg/kg |
Withdrawn |
Study Name: Increlex Treatment of Children With Chronic Liver Disease and Short Stature Condition: Growth Failure Chronic Liver Disease Date: 2011-03-08 Interventions: Drug: Increlex Increlex therapy will begin at 40 micrograms/kg/day twice a day. The dose will be escalat |
Completed |
Study Name: Ghrelin Levels in Children With Poor Growth Condition: Idiopathic Short Stature Failure to Thrive Date: 2010-02-12 |
Completed |
Study Name: Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT) Condition: Ataxia Telangiectasia Growth Failure Date: 2010-01-19 Interventions: Drug: Somatropin, Clonidine, L-Arginin-Hydrochloride, Estradiol valerate 1 mg Estradiol valerate with fo |
Completed |
Study Name: r-hGH Liquid Multidose Versus Freeze-dried Multidose Bioequivalence Trial Condition: Growth Failure Growth Hormone Deficiency Date: 2009-12-16 Interventions: Biological: r-hGH liquid (Saizen) |
Withdrawn |
Study Name: Safety Study of Infant Formula With Partially Hydrolized Whey Condition: Growth Failure Date: 2007-10-22 Interventions: Dietary Supplement: partially hydrolyzed whey |
Terminated |
Study Name: Treatment for Growth Failure in Patients With X-Linked Severe Combined Immunodeficiency: Phase 2 Study of Insulin-Like Growth Factor-1 Condition: Growth Failure X-linked Severe Combined Immunodeficiency (XSCID Date: 2007-06-21 Interventions: Drug: Increlex |
Completed |
Study Name: Trial of Home Visitation Among Infants With Failure To Thrive Condition: Failure to Thrive Date: 2007-06-05 Interventions: Behavioral: Home Visit Homw visits scheduled weekly for one year. |
Terminated |
Study Name: Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency Condition: Growth Disorders Date: 2006-05-26 Interventions: Drug: rh IGF-1 (mecasermin) Patients from untreated arm for prior study MS301 (NCT00125164) were randomi |